APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacokinetics Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmacokinetics Software Market Outlook and Growth Opportunities 2026

8 January 2026197 pages

Choose your research edition.

Industry ResearchPharmacokinetics Software Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacokinetics Software Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Pharmacokinetics Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacokinetics Software Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacokinetics Software Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pharmacokinetics Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmacokinetics Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacokinetics Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacokinetics Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmacokinetics Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmacokinetics Software market include Certara, Simulations Plus, IntiQuan GmbH, Bayer, Genedata AG, Thermo Scientific, SGS, Pharmaron and Pumas-AI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmacokinetics Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacokinetics Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacokinetics Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmacokinetics Software market.

Pharmacokinetics Software Segment by Company

Certara

Simulations Plus

IntiQuan GmbH

Bayer

Genedata AG

Thermo Scientific

SGS

Pharmaron

Pumas-AI

PharmoGo

Chuangteng Technology

Medixi Biomedical

Pharmacokinetics Software Segment by Type

Compartmental Model

Non-Compartmental Models

Pharmacokinetics Software Segment by Application

Experimental Design

Clinical Pharmacokinetics

Other

Pharmacokinetics Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmacokinetics Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmacokinetics Software key companies, revenue, market share, and recent developments.

3. To split the Pharmacokinetics Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmacokinetics Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmacokinetics Software significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmacokinetics Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetics Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetics Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetics Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacokinetics Software industry.

Chapter 3: Detailed analysis of Pharmacokinetics Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmacokinetics Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmacokinetics Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmacokinetics Software Industry Trends Table 2. Pharmacokinetics Software Industry Drivers Table 3. Pharmacokinetics Software Industry Opportunities and Challenges Table 4. Pharmacokinetics Software Industry Restraints Table 5. Global Pharmacokinetics Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmacokinetics Software Revenue Share by Company (2021-2026) Table 7. Global Pharmacokinetics Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmacokinetics Software Key Company Manufacturing Base & Headquarters Table 9. Global Pharmacokinetics Software Company, Product Type & Application Table 10. Global Pharmacokinetics Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmacokinetics Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Compartmental Model Table 15. Significant Companies of Non-Compartmental Models Table 16. Global Pharmacokinetics Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pharmacokinetics Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pharmacokinetics Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pharmacokinetics Software Sales Value Share by Type (2021-2026) Table 20. Global Pharmacokinetics Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Experimental Design Table 22. Significant Companies of Clinical Pharmacokinetics Table 23. Significant Companies of Other Table 24. Global Pharmacokinetics Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmacokinetics Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pharmacokinetics Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pharmacokinetics Software Sales Value Share by Application (2021-2026) Table 28. Global Pharmacokinetics Software Sales Value Share by Application (2027-2032) Table 29. Global Pharmacokinetics Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pharmacokinetics Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pharmacokinetics Software Sales Value Share by Region (2021-2026) Table 32. Global Pharmacokinetics Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pharmacokinetics Software Sales Value Share by Region (2027-2032) Table 34. Global Pharmacokinetics Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pharmacokinetics Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pharmacokinetics Software Sales Value Market Share by Country (2021-2026) Table 37. Global Pharmacokinetics Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pharmacokinetics Software Sales Value Market Share by Country (2027-2032) Table 39. Certara Company Information Table 40. Certara Business Overview Table 41. Certara Pharmacokinetics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Certara Pharmacokinetics Software Product Portfolio Table 43. Certara Recent Development Table 44. Simulations Plus Company Information Table 45. Simulations Plus Business Overview Table 46. Simulations Plus Pharmacokinetics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Simulations Plus Pharmacokinetics Software Product Portfolio Table 48. Simulations Plus Recent Development Table 49. IntiQuan GmbH Company Information Table 50. IntiQuan GmbH Business Overview Table 51. IntiQuan GmbH Pharmacokinetics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. IntiQuan GmbH Pharmacokinetics Software Product Portfolio Table 53. IntiQuan GmbH Recent Development Table 54. Bayer Company Information Table 55. Bayer Business Overview Table 56. Bayer Pharmacokinetics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Bayer Pharmacokinetics Software Product Portfolio Table 58. Bayer Recent Development Table 59. Genedata AG Company Information Table 60. Genedata AG Business Overview Table 61. Genedata AG Pharmacokinetics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Genedata AG Pharmacokinetics Software Product Portfolio Table 63. Genedata AG Recent Development Table 64. Thermo Scientific Company Information Table 65. Thermo Scientific Business Overview Table 66. Thermo Scientific Pharmacokinetics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Thermo Scientific Pharmacokinetics Software Product Portfolio Table 68. Thermo Scientific Recent Development Table 69. SGS Company Information Table 70. SGS Business Overview Table 71. SGS Pharmacokinetics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. SGS Pharmacokinetics Software Product Portfolio Table 73. SGS Recent Development Table 74. Pharmaron Company Information Table 75. Pharmaron Business Overview Table 76. Pharmaron Pharmacokinetics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pharmaron Pharmacokinetics Software Product Portfolio Table 78. Pharmaron Recent Development Table 79. Pumas-AI Company Information Table 80. Pumas-AI Business Overview Table 81. Pumas-AI Pharmacokinetics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pumas-AI Pharmacokinetics Software Product Portfolio Table 83. Pumas-AI Recent Development Table 84. PharmoGo Company Information Table 85. PharmoGo Business Overview Table 86. PharmoGo Pharmacokinetics Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. PharmoGo Pharmacokinetics Software Product Portfolio Table 88. PharmoGo Recent Development Table 89. Chuangteng Technology Company Information Table 90. Chuangteng Technology Business Overview Table 91. Chuangteng Technology Pharmacokinetics Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Chuangteng Technology Pharmacokinetics Software Product Portfolio Table 93. Chuangteng Technology Recent Development Table 94. Medixi Biomedical Company Information Table 95. Medixi Biomedical Business Overview Table 96. Medixi Biomedical Pharmacokinetics Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Medixi Biomedical Pharmacokinetics Software Product Portfolio Table 98. Medixi Biomedical Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Pharmacokinetics Software Product Image Figure 2. Global Pharmacokinetics Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacokinetics Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmacokinetics Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Compartmental Model Image Figure 8. Non-Compartmental Models Image Figure 9. Global Pharmacokinetics Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pharmacokinetics Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pharmacokinetics Software Sales Value Share by Type (2021-2032) Figure 12. Experimental Design Image Figure 13. Clinical Pharmacokinetics Image Figure 14. Other Image Figure 15. Global Pharmacokinetics Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pharmacokinetics Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pharmacokinetics Software Sales Value Share by Application (2021-2032) Figure 18. Global Pharmacokinetics Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pharmacokinetics Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pharmacokinetics Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pharmacokinetics Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pharmacokinetics Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pharmacokinetics Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pharmacokinetics Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pharmacokinetics Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pharmacokinetics Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pharmacokinetics Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pharmacokinetics Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pharmacokinetics Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pharmacokinetics Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Compartmental Model
  • Non-Compartmental Models
Applications
  • Experimental Design
  • Clinical Pharmacokinetics
  • Other
Companies covered
  • Certara
  • Simulations Plus
  • IntiQuan GmbH
  • Bayer
  • Genedata AG
  • Thermo Scientific
  • SGS
  • Pharmaron
  • Pumas-AI
  • PharmoGo
  • Chuangteng Technology
  • Medixi Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmacokinetics Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmacokinetics Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmacokinetics Software Market Dynamics
  1. 2.1 Pharmacokinetics Software Industry Trends
  2. 2.2 Pharmacokinetics Software Industry Drivers
  3. 2.3 Pharmacokinetics Software Industry Opportunities and Challenges
  4. 2.4 Pharmacokinetics Software Industry Restraints
3 Pharmacokinetics Software Market by Company
  1. 3.1 Global Pharmacokinetics Software Company Revenue Ranking in 2025
  2. 3.2 Global Pharmacokinetics Software Revenue by Company (2021-2026)
  3. 3.3 Global Pharmacokinetics Software Company Ranking (2024-2026)
  4. 3.4 Global Pharmacokinetics Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmacokinetics Software Company Product Type and Application
  6. 3.6 Global Pharmacokinetics Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmacokinetics Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmacokinetics Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmacokinetics Software Market by Type
  1. 4.1 Pharmacokinetics Software Type Introduction
  2. 4.1.1 Compartmental Model
  3. 4.1.2 Non-Compartmental Models
  4. 4.2 Global Pharmacokinetics Software Sales Value by Type
  5. 4.2.1 Global Pharmacokinetics Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmacokinetics Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pharmacokinetics Software Sales Value Share by Type (2021-2032)
5 Pharmacokinetics Software Market by Application
  1. 5.1 Pharmacokinetics Software Application Introduction
  2. 5.1.1 Experimental Design
  3. 5.1.2 Clinical Pharmacokinetics
  4. 5.1.3 Other
  5. 5.2 Global Pharmacokinetics Software Sales Value by Application
  6. 5.2.1 Global Pharmacokinetics Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmacokinetics Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmacokinetics Software Sales Value Share by Application (2021-2032)
6 Pharmacokinetics Software Regional Value Analysis
  1. 6.1 Global Pharmacokinetics Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmacokinetics Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmacokinetics Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmacokinetics Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmacokinetics Software Sales Value (2021-2032)
  7. 6.3.2 North America Pharmacokinetics Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmacokinetics Software Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmacokinetics Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmacokinetics Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmacokinetics Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmacokinetics Software Sales Value (2021-2032)
  16. 6.6.2 South America Pharmacokinetics Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmacokinetics Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmacokinetics Software Sales Value Share by Country, 2025 VS 2032
7 Pharmacokinetics Software Country-level Value Analysis
  1. 7.1 Global Pharmacokinetics Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmacokinetics Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmacokinetics Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmacokinetics Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmacokinetics Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmacokinetics Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmacokinetics Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Certara
  2. 8.1.1 Certara Company Information
  3. 8.1.2 Certara Business Overview
  4. 8.1.3 Certara Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Certara Pharmacokinetics Software Product Portfolio
  6. 8.1.5 Certara Recent Developments
  7. 8.2 Simulations Plus
  8. 8.2.1 Simulations Plus Company Information
  9. 8.2.2 Simulations Plus Business Overview
  10. 8.2.3 Simulations Plus Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Simulations Plus Pharmacokinetics Software Product Portfolio
  12. 8.2.5 Simulations Plus Recent Developments
  13. 8.3 IntiQuan GmbH
  14. 8.3.1 IntiQuan GmbH Company Information
  15. 8.3.2 IntiQuan GmbH Business Overview
  16. 8.3.3 IntiQuan GmbH Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 IntiQuan GmbH Pharmacokinetics Software Product Portfolio
  18. 8.3.5 IntiQuan GmbH Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Pharmacokinetics Software Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Genedata AG
  26. 8.5.1 Genedata AG Company Information
  27. 8.5.2 Genedata AG Business Overview
  28. 8.5.3 Genedata AG Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Genedata AG Pharmacokinetics Software Product Portfolio
  30. 8.5.5 Genedata AG Recent Developments
  31. 8.6 Thermo Scientific
  32. 8.6.1 Thermo Scientific Company Information
  33. 8.6.2 Thermo Scientific Business Overview
  34. 8.6.3 Thermo Scientific Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Thermo Scientific Pharmacokinetics Software Product Portfolio
  36. 8.6.5 Thermo Scientific Recent Developments
  37. 8.7 SGS
  38. 8.7.1 SGS Company Information
  39. 8.7.2 SGS Business Overview
  40. 8.7.3 SGS Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SGS Pharmacokinetics Software Product Portfolio
  42. 8.7.5 SGS Recent Developments
  43. 8.8 Pharmaron
  44. 8.8.1 Pharmaron Company Information
  45. 8.8.2 Pharmaron Business Overview
  46. 8.8.3 Pharmaron Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pharmaron Pharmacokinetics Software Product Portfolio
  48. 8.8.5 Pharmaron Recent Developments
  49. 8.9 Pumas-AI
  50. 8.9.1 Pumas-AI Company Information
  51. 8.9.2 Pumas-AI Business Overview
  52. 8.9.3 Pumas-AI Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pumas-AI Pharmacokinetics Software Product Portfolio
  54. 8.9.5 Pumas-AI Recent Developments
  55. 8.10 PharmoGo
  56. 8.10.1 PharmoGo Company Information
  57. 8.10.2 PharmoGo Business Overview
  58. 8.10.3 PharmoGo Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PharmoGo Pharmacokinetics Software Product Portfolio
  60. 8.10.5 PharmoGo Recent Developments
  61. 8.11 Chuangteng Technology
  62. 8.11.1 Chuangteng Technology Company Information
  63. 8.11.2 Chuangteng Technology Business Overview
  64. 8.11.3 Chuangteng Technology Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Chuangteng Technology Pharmacokinetics Software Product Portfolio
  66. 8.11.5 Chuangteng Technology Recent Developments
  67. 8.12 Medixi Biomedical
  68. 8.12.1 Medixi Biomedical Company Information
  69. 8.12.2 Medixi Biomedical Business Overview
  70. 8.12.3 Medixi Biomedical Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Medixi Biomedical Pharmacokinetics Software Product Portfolio
  72. 8.12.5 Medixi Biomedical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst